Expression of noggin, an antagonist of bone morphogenetic protein, in schwannoma: A possible mechanism

Kaneko,Keiko; Higuchi,Chikahisa; Naka,Norifumi; Yoshikawa,Hideki

doi:10.3892/ol.2014.2138

Expression of noggin, an antagonist of bone morphogenetic protein, in schwannoma: A possible mechanism

Authors:
- Keiko Kaneko
- Chikahisa Higuchi
- Norifumi Naka
- Hideki Yoshikawa
View Affiliations

Affiliations: Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka 565‑0871, Japan
Published online on: May 12, 2014 https://doi.org/10.3892/ol.2014.2138
Pages: 111-116

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Schwannoma is a benign peripheral nerve sheath tumor derived from Schwann cells. Bone scalloping, including spinal foramen enlargement, develops when the tumor is located adjacent to a bone and is a characteristic radiological feature. In the present study, to investigate the pathomechanism of bone resorption, the expression of noggin (a potent antagonist of bone morphogenetic protein) was analyzed in schwannoma tissues and compared with that observed in other soft tissue tumors. Quantitative polymerase chain reaction analysis revealed that the mRNA levels of noggin in schwannomas were significantly increased compared with the levels in other tumors. The gene product of noggin was only detected in a subset of schwannomas using immunohistochemistry and western blot analysis. Furthermore, the tissue extract from a noggin‑producing schwannoma was found to inhibit osteoblastic differentiation in MC3T3 mouse osteoblastic cells in a dose‑dependent manner. These findings indicate that bone scalloping in radiology may be induced by schwannoma‑secreted noggin. In addition, noggin may have potential as a novel molecular and diagnostic marker for identifying certain types of schwannoma.

View Figures

View References

1	Chick G, Alnot JY and Silbermann-Hoffman O: Benign solitary tumors of the peripheral nerves. Rev Chir Orthop Reparatrice Appar Mot. 86:825–834. 2000.(In French).
2	Knight DM, Birch R and Pringle J: Benign solitary schwannomas: a review of 234 cases. J Bone Joint Surg Br. 89:382–387. 2007.
3	Amirjamshidi A, Hashemi SM and Abbassioun K: Schwannoma of the greater superficial petrosal nerve. J Neurosurg. 113:1093–1098. 2010.
4	Ikushima K, Ueda T, Kudawara I, Nakanishi K and Yoshikawa H: Plexiform schwannoma of the foot. Eur Radiol. 9:1653–1655. 1999.
5	Agarwal K, Agarwal C, Agarwal M and Harbhajanka A: Plexiform schwannoma of scalp: a case report with brief review of literature. Indian J Pathol Microbiol. 50:797–799. 2007.
6	Singson RD, Dee G and Quader MA: Case report 265. Scalloping and destruction of pedicles of lumbar vertebral bodies on the right side secondary to venous collaterals, associated with thrombosis of the inferior ±vena cava. Skeletal Radiol. 11:293–295. 1984.
7	Inaoka T, Takahashi K, Hanaoka H, et al: Paravertebral neurinoma associated with aggressive intravertebral extension. Skeletal Radiol. 30:286–289. 2001.
8	Singrakhia MD, Parmar H, Maheshwari M and Fehlings M: Cervical schwannoma presenting as an expansile vertebral body lesion: report of two cases with a technical note on the surgical management. Surg Neurol. 66:192–196. 2006.
9	Nakamura Y, Wakitani S, Nakayama J, Wakabayashi S, Horiuchi H and Takaoka K: Temporal and spatial expression profiles of BMP receptors and noggin during BMP-2-induced ectopic bone formation. J Bone Miner Res. 18:1854–1862. 2003.
10	Tylzanowski P, Mebis L and Luyten FP: The Noggin null mouse phenotype is strain dependent and haploinsufficiency leads to skeletal defects. Dev Dyn. 235:1599–1607. 2006.
11	Devlin RD, Du Z, Pereira RC, Kimble RB, Economides AN, Jorgetti V and Canalis E: Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology. 144:1972–1978. 2003.
12	Gazzerro E, Gangji V and Canalis E: Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J Clin Invest. 102:2106–2114. 1998.
13	Bachiller D, Klingensmith J, Kemp C, et al: The organizer factors Chordin and Noggin are required for mouse forebrain development. Nature. 403:658–661. 2000.
14	Krause C, Guzman A and Knaus P: Noggin. Int J Biochem Cell Biol. 43:478–481. 2011.
15	Bonaguidi MA, Peng CY, McGuire T, et al: Noggin expands neural stem cells in the adult hippocampus. J Neurosci. 28:9194–9204. 2008.
16	Li W and LoTurco JJ: Noggin is a negative regulator of neuronal differentiation in developing neocortex. Dev Neurosci. 22:68–73. 2000.
17	Fletcher CDM, Unni KK and Mertens F: Pathology and Genetics of Tumours of Soft Tissue and Bone. 4. World Health Organisation; Lyon: 2002
18	Miyazono K, Kamiya Y and Morikawa M: Bone morphogenetic protein receptors and signal transduction. J Biochem. 147:35–51. 2010.
19	Takayama K, Suzuki A, Manaka T, et al: RNA interference for noggin enhances the biological activity of bone morphogenetic proteins in vivo and in vitro. J Bone Miner Metab. 27:402–411. 2009.
20	Yoshimura Y, Nomura S, Kawasaki S, Tsutsumimoto T, Shimizu T and Takaoka K: Colocalization of noggin and bone morphogenetic protein-4 during fracture healing. J Bone Miner Res. 16:876–884. 2001.
21	Nakase T, Nomura S, Yoshikawa H, et al: Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res. 9:651–659. 1994.
22	Brunet LJ, McMahon JA, McMahon AP and Harland RM: Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science. 280:1455–1457. 1998.
23	Holley SA, Neul JL, Attisano L, et al: The Xenopus dorsalizing factor noggin ventralizes Drosophila embryos by preventing DPP from activating its receptor. Cell. 86:607–617. 1996.
24	Iemura S, Yamamoto TS, Takagi C, et al: Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci USA. 95:9337–9342. 1998.
25	Zimmerman LB, De Jesús-Escobar JM and Harland RM: The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell. 86:599–606. 1996.
26	Mikawa S and Sato K: Noggin expression in the adult rat brain. Neuroscience. 184:38–53. 2011.
27	Asahara H, Kawai A, Harada Y, Senda M and Inoue H: Spinal schwannomas: a review of 42 cases. Acta Med Okayama. 50:25–28. 1996.
28	Chibbaro S, Mirone G, Makiese O, Bresson D and George B: Dumbbell-shaped jugular foramen schwannomas: surgical management, outcome and complications on a series of 16 patients. Neurosurg Rev. 32:151–159. 2009.
29	Yokota H, Isobe K, Murakami M, Kubosawa H and Uno T: Dumbbell-shaped nonpsammomatous malignant melanotic schwannoma of the cervical spinal root. Spine J. 12:e14–e17. 2012.
30	Piek J: Giant schwannoma of the cauda equina without neurological deficits - case report and review of the literature. Wien Klin Wochenschr. 122:645–648. 2010.
31	Jankowski R, Szmeja J, Nowak S, Sokół B and Blok T: Giant schwannoma of the lumbar spine. A case report. Neurol Neurochir Pol. 44:91–95. 2010.